February 19, 2017
Recommended Topic Related To:

Arcapta Neohaler

"The US Food and Drug Administration (FDA) has expanded the use of the cystic fibrosis (CF) drug Orkambi (Vertex Pharmaceuticals) to children aged 6 to 11 years who have two copies of the F508del mutation in the CF transmembrane conductance"...

A A A

Arcapta Neohaler




PATIENT INFORMATION

No information provided. Please refer to the WARNINGS AND PRECAUTIONS section.

Last reviewed on RxList: 11/7/2016
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.